EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+4.07%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$248M
AUM Growth
+$248M
(-8.2%)
Cap. Flow
-$3.24M
Cap. Flow
% of AUM
-1.31%
Top 10 Holdings %
Top 10 Hldgs %
65.09%
Holding
42
New
10
Increased
7
Reduced
9
Closed
6
Top Buys
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$13.6M |
| 2 |
EPZM
Epizyme, Inc
EPZM
|
$10.9M |
| 3 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$10.5M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$7.13M |
| 5 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$7.07M |
Top Sells
| 1 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$44.5M |
| 2 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$8.87M |
| 3 |
FibroGen
FGEN
|
$7.51M |
| 4 |
Tempest Therapeutics
TPST
|
$4.15M |
| 5 |
GNVC
GenVec, Inc.
GNVC
|
$3.53M |
Sector Composition
| 1 | Healthcare | 79.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
26
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $445K | 0.16% | +28,032 | New | +$445K |
|
|
ATYR
27
aTyr Pharma
ATYR
$527M
| $295K | 0.1% | 74,959 -715,503 | -91% | -$2.82M |
|
|
ONCE
28
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $257K | 0.09% | +8,700 | New | +$257K |
|
29
Bausch Health
BHC
$2.74B
| – | – | 0 | – | – |
|
30
Gilead Sciences
GILD
$140B
| – | – | 0 | – | – |
|
31
Jazz Pharmaceuticals
JAZZ
$7.75B
| – | – | 0 | – | – |
|
32
Larimar Therapeutics
LRMR
$310M
| – | – | -369,000 | Closed | -$2.32M |
|
|
33
Tempest Therapeutics
TPST
$44M
| – | – | -424,979 | Closed | -$4.15M |
|
34
SPDR NYSE Technology ETF
XNTK
$1.25B
| – | – | 0 | – | – |
|
|
IMGN
35
DELISTED
Immunogen Inc
IMGN
| – | – | 0 | – | – |
|
|
CALA
36
DELISTED
Calithera Biosciences, Inc
CALA
| – | – | -415,480 | Closed | -$3.18M |
|
|
ARRY
37
DELISTED
Array Biopharma Inc
ARRY
| – | – | 0 | – | – |
|
|
QLTI
38
DELISTED
QLT Inc
QLTI
| – | – | -100,000 | Closed | -$266K |
|
|
NRX
39
DELISTED
NEPHROGENEX INC COM
NRX
| – | – | -588,235 | Closed | -$941K |
|
|
GNVC
40
DELISTED
GenVec, Inc.
GNVC
| – | – | -1,920,913 | Closed | -$3.53M |
|